Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
8.29
+1.07 (14.82%)
At close: Aug 20, 2026, 4:00 PM EDT
8.30
+0.01 (0.12%)
Pre-market: Aug 21, 2026, 5:19 AM EDT
MRVI Revenue
Maravai LifeSciences Holdings had revenue of $51.44M in the quarter ending June 30, 2026, with 8.53% growth. This brings the company's revenue in the last twelve months to $208.78M, down -5.03% year-over-year. In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%.
Revenue (ttm)
$208.78M
Revenue Growth
-5.03%
P/S Ratio
10.31
Revenue / Employee
$503,072
Employees
415
Market Cap
2.15B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 185.74M | -73.44M | -28.34% |
| Dec 31, 2024 | 259.19M | -29.76M | -10.30% |
| Dec 31, 2023 | 288.95M | -594.06M | -67.28% |
| Dec 31, 2022 | 883.00M | 83.76M | 10.48% |
| Dec 31, 2021 | 799.24M | 515.14M | 181.33% |
| Dec 31, 2020 | 284.10M | 140.96M | 98.48% |
| Dec 31, 2019 | 143.14M | 19.31M | 15.59% |
| Dec 31, 2018 | 123.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Lakefront Biotherapeutics NV | 1.13B |
| Immunocore Holdings | 430.78M |
| Syndax Pharmaceuticals | 252.25M |
| AnaptysBio | 232.39M |
| Intellia Therapeutics | 59.51M |
| Recursion Pharmaceuticals | 54.86M |
| Zymeworks | 37.13M |
MRVI News
- 1 day ago - Stifel sees Moderna data as positive for Repligen, Maravai - TheFly
- 14 days ago - Maravai LifeSciences Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - Maravai LifeSciences Holdings Earnings release: Q2 2026 - Filings
- 14 days ago - Maravai LifeSciences Holdings Slides: Q2 2026 - Filings
- 14 days ago - Maravai LifeSciences Holdings Quarterly report: Q2 2026 - Filings
- 14 days ago - Maravai LifeSciences Reports Second Quarter 2026 Financial Results - Business Wire
- 19 days ago - Maravai LifeSciences Holdings Slides: Investor presentation - Filings
- 4 weeks ago - Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026 - Business Wire